Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-24-081603

Options or other derivatives

  • Director acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Amin Dipti · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X05/ownership.xml…